N
NOX
NOXOPHARM LIMITED
0.058
-0.002-3.33%Closed15:08 04/08 AEST
OPEN/PREV CLOSE0.060/0.060
TODAY RANGE0.057-0.060
VOL250.57K
MARKET CAP17.82M
52 WEEK RANGE0.043-0.135
AVG VOL (3M)231.20K
% TURNOVER0.08%
TURNOVER14.62K
P/E (TTM)-3.0851
% RANGE5.00%
EPS(TTM)-0.0188
P/E(FORWARD)--
P/B-14.8718
BVPS-0.0039
DIVIDEND--
P/S5.98
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP12.16M
SHARES OUTSTANDING307.24M
NEXT EARNINGS07/28-08/03
FREE FLOAT209.68M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
ASX·02/27 02:42
Appendix 4D and FY2026 Half Year Financial Report
ASX·02/26 22:50
Notice under Section 708A(5)(e) of the Corps Act
ASX·02/26 22:48
Application for quotation of securities - NOX
ASX·02/26 22:36
R&D rebate strengthens cash position
ASX·02/26 22:08
At-the-Market (ATM) agreement with Acuity Capital
ASX·02/10 21:18
Sofra breakthrough science publish in major medical journal
ASX·01/29 22:10
December 2025 Quarterly Activities Report and Appendix 4C
ASX·01/20 22:02
HERACLES clinical trial successfully completed
ASX·01/01 22:18
Notice under s708A(12C)(e) of the Corporations Act 2001
ASX·01/01 22:08
Notification regarding unquoted securities - NOX
ASX·01/01 22:04
Notification of cessation of securities - NOX
ASX·12/11/2025 22:50
Change of Director's Interest Notice - FB
ASX·12/11/2025 22:44
Notice under s708A(12C)(e) of the Corporations Act 2001
ASX·12/11/2025 22:36
Notification regarding unquoted securities - NOX
ASX·12/02/2025 21:24
HERACLES clinical trial Update 5
Same Industry
Name/Symbol
Change%
Price
No data yet, let's see others